SCULPTRA® TREATMENT

A course of two to three treatment sessions may be recommended. The appropriate number and timing of appointments depend on the areas treated, degree of volume loss, number of vials and individual response.

Your treatment schedule will be confirmed following consultation.

Sculptra contains poly L lactic acid. Once placed into suitable tissues, it encourages fibroblast activity and collagen production around the treated area.

The product is gradually metabolised while changes associated with collagen development occur over the following weeks and months.

Sculptra may address selected areas of facial volume loss while supporting skin firmness and quality. It is often planned across broader facial areas rather than used to fill an individual line.

Facial ageing can have several causes, so Rupesh will assess whether Sculptra or another treatment is more appropriate.

Temporary fullness may be visible immediately because of the water used to prepare the product. This effect settles.

Changes associated with collagen development may begin to appear over approximately six to twelve weeks and can continue developing over several months. The timing and extent of results vary.

Downtime is generally limited, but swelling, redness, tenderness, bruising, itching or temporary unevenness may occur around the injection sites.

These effects commonly settle within several days. Follow the aftercare instructions provided and contact the clinic if symptoms are severe, worsening or unexpected.

Hyaluronic acid dermal fillers provide physical volume immediately and can be used for precise contouring or definition.

Sculptra is a collagen-stimulating treatment. Its effects develop gradually, and it cannot be dissolved with hyaluronidase. The appropriate option depends on your anatomy, concerns and desired timeframe.

Sculptra may be incorporated into a wider treatment plan alongside dermal fillers, polynucleotides, skin boosters, microneedling or anti-wrinkle treatment where appropriate.

Some procedures need to be separated by a suitable interval. Rupesh will advise on the appropriate sequence.

Sculptra may be suitable for adults with selected areas of facial volume loss who prefer gradual changes rather than immediate correction.

Suitability depends on medical history, facial anatomy, skin condition and treatment goals. A consultation is required before treatment.

Collagen development may support gradual improvements in skin firmness, texture and overall quality around suitable treatment areas.

The degree of improvement varies, and Sculptra should not be expected to correct every type of skin concern.

Sculptra may help selected areas affected by volume loss. Its ability to improve the appearance of sagging depends on the cause and severity of the concern.

It does not remove excess skin or produce the same result as a surgical lifting procedure.

Treatment starts from £400 per vial. The total cost depends on the number of vials, areas being treated and the number of sessions recommended.

You will receive a personalised quotation following your consultation.

The number of vials depends on your facial anatomy, degree of volume loss, treatment areas and goals. A limited area may require fewer vials than a broader facial treatment plan.

Rupesh will assess your needs before making a recommendation.

Possible reactions include swelling, redness, tenderness, bruising, itching, discomfort and temporary unevenness.

Less commonly, lumps, papules or nodules may develop. Some can appear weeks or months after treatment. Other potential complications include infection, inflammation, allergic reaction, asymmetry and an unsatisfactory cosmetic result.

All relevant risks will be discussed during your consultation.

Contact London Lip Clinic if you experience:

• Severe or worsening pain
• Increasing redness, warmth or swelling
• Discharge or fever
• A persistent, painful or inflamed lump
• Unusual skin discolouration
• Visual symptoms
• Any unexpected reaction that causes concern

Seek urgent medical attention for difficulty breathing, significant facial swelling, visual disturbance or signs of a serious allergic reaction.

Sculptra may not be appropriate during pregnancy or breastfeeding, in the presence of an active infection or inflammation, or for someone with a known allergy to the product’s ingredients.

People with certain medical conditions, medication requirements or a history of keloid or hypertrophic scarring may also be unsuitable. Rupesh will review these factors during consultation.

Sculptra is an established injectable product available for aesthetic use in the UK. It should only be administered by an appropriately trained practitioner following an individual consultation and suitability assessment.

No. Sculptra cannot be dissolved with hyaluronidase or immediately reversed in the way that many hyaluronic acid fillers can.

This makes careful assessment, product preparation, placement and conservative treatment planning especially important.

Sculptra may be considered for selected patients concerned about skin quality in these areas. Suitability depends on the condition and thickness of the skin, the product guidance and the practitioner’s assessment.

Another skin treatment may sometimes be more appropriate.

Sculptra should not be injected directly into the lips or delicate under-eye area.

Where under-eye hollowing is influenced by mid-face volume loss, treatment of suitable cheek or mid-face areas may affect overall facial balance. Rupesh will assess the concern and discuss safer, more appropriate alternatives where necessary.